课题基金 / 基金详情

Biochemistry and Regulation of V(D)J Recombination

Biochemistry and Regulation of V(D)J Recombination
V(D)J 重组的生物化学和调控
批准号:
7433339
负责人:
Mark S. Schlissel
金额:
$34.3万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-07-01 至 2010-05-31

项目摘要

项目成果

Mark S. Schlissel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The genes which encode immunoglobulin and T cell receptor molecules are assembled from V, D, and J gene-segments by a novel series of site-specific DNA recombination reactions known as V(D)J recombination. The recombinase consists of the lymphocyte-specific proteins RAG1 and RAG2 and the widely expressed non-homologous end-joining proteins. The recombinase recognizes conserved recombination signal sequences (RSSs) which flank gene segments and introduces dsDNA breaks which are repaired to form coding and signal joints. Recombination at the seven complex antigen-receptor loci in B and T cells is regulated with respect to lineage specificity, order within a lineage, and allelic exclusion. We and others have shown that V(D)J recombination is regulated in part by the accessibility of RSSs within chromatin structure and that germline transcription of unrearranged gene segments either reflects or actually causes chromatin accessibility. The central goal of this proposal is to understand, at the biochemical level, the mechanisms which dictate the biological regulation of V(D)J recombination. This goal will be pursued through pursuit of the following specific aims: 1) to determine the location and structure of nucleosomes across the J-kappa cluster of gene segments and how nucleosomes are disrupted to allow recombinase accessibility; 2) to determine whether the V(D)J recombinase nicks DNA in vivo and whether the conversion from nicked to broken DNA is a regulated step in the reaction; 3) to determine the catalytic properties in vivo of a core-domain mutant of RAG2; and 4) to define the role of transcriptional regulatory elements in the regulation of V(D)J recombination. This work is significant because of the essential role of antigen receptors in acquired immunity and the potential involvement of the recombinase in generation of chromosomal translocations associated with lymphoid malignancies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
c-Abl and PKC-eta in Cell Development and Leukemia
  • 批准号:
    7056186
  • 项目类别:
  • 资助金额:
    $36.69万
  • 财政年份:
    2004
  • 负责人:
    Mark S. Schlissel
  • 依托单位:
c-Abl and PKC-eta in Cell Development and Leukemia
  • 批准号:
    7406795
  • 项目类别:
  • 资助金额:
    $35.35万
  • 财政年份:
    2004
  • 负责人:
    Mark S. Schlissel
  • 依托单位:
c-Abl and PKC-eta in Cell Development and Leukemia
  • 批准号:
    6887407
  • 项目类别:
  • 资助金额:
    $37.61万
  • 财政年份:
    2004
  • 负责人:
    Mark S. Schlissel
  • 依托单位:
c-Abl and PKC-eta in Cell Development and Leukemia
  • 批准号:
    7226339
  • 项目类别:
  • 资助金额:
    $36.03万
  • 财政年份:
    2004
  • 负责人:
    Mark S. Schlissel
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究